{"name":"Institut de Cancérologie de Lorraine","slug":"institut-de-canc-rologie-de-lorraine","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Adjuvant chemotherapy","genericName":"Adjuvant chemotherapy","slug":"adjuvant-chemotherapy","indication":"Adjuvant treatment of various solid tumors (breast cancer, colorectal cancer, gastric cancer, ovarian cancer, and others depending on regimen)","status":"marketed"}]}],"pipeline":[{"name":"Adjuvant chemotherapy","genericName":"Adjuvant chemotherapy","slug":"adjuvant-chemotherapy","phase":"marketed","mechanism":"Adjuvant chemotherapy uses cytotoxic drugs administered after primary cancer treatment to eliminate residual cancer cells and reduce recurrence risk.","indications":["Adjuvant treatment of various solid tumors (breast cancer, colorectal cancer, gastric cancer, ovarian cancer, and others depending on regimen)","Post-operative or post-radiation therapy to reduce recurrence risk"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNRGJvY2tPSTlMZGdEdWc5NEE0R0w4cG5ZTlZaZzdTUE10aF9hMW4xSlR4a0xib29SSHVleTBKSHM2ZzhwM05mTzZxZzdzMlEzYXJjbzJPemwySE9tM01aLWJtZC1xTjNqamRCSExpMnY1eHJvdVl0NUUya3ltbkV1YldYcVl1S0FrcXdVZHN0c0VSaGNvQ0JxcFZNMUJqMlZNR2ltZ1NjNFdlbi02U1Z1SA?oc=5","date":"2026-01-06","type":"pipeline","source":"BioSpace","summary":"SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer - BioSpace","headline":"SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQU0dja3FkQm1tempZZi14YlgyakpBX2p3bTF2YlUyNnBwR0FCai1kb3Riai12dWxDUG1OZkVMUzVvejA1eGdrUFo1TE9Db05oS3Fmd3JfQTFYYUdtQ25EWDNXWEk1T1RCV1lxVEdsQm0yRGhjeGpCYUFDMnREVFJFRG5SRmpNTWdlMEcxUy16VExjZFhmZkh3bzRzdFJoWlZoYzIyZE5PaDR4U09LZGhTRklEamg2RGFfRUE?oc=5","date":"2023-06-09","type":"pipeline","source":"Cancer Therapy Advisor","summary":"TNT With mFOLFIRINOX Outperforms Standard Care for Locally Advanced Rectal Cancer - Cancer Therapy Advisor","headline":"TNT With mFOLFIRINOX Outperforms Standard Care for Locally Advanced Rectal Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQMDhOdmxzZGM5VlNya0NnY1ZKM3JObGZmc0haY1Z5eGdZOGgzajNxRWhCbTVmaFMyTG9fWEFsSEdRdlo3YWtQNy13UEJUOXo4TGVzUG45cmtZRTJ0ZmRVQ3FRbTE5VHFQNzltVE1SUXBtMGtSU2xTRVZ6Q2haV0FyaTRDTDhfLVpKaTJPbzFkVm9iVjkzMUpueFBqYW5tTE5iLWN6X19CbkVzUHZ3aWhoUEFYc1VxZw?oc=5","date":"2023-06-04","type":"pipeline","source":"ASCO Daily News","summary":"PRODIGE-23: 7-Year Results Indicate Durable Benefit of Induction Chemotherapy in Locally Advanced Rectal Cancer - ASCO Daily News","headline":"PRODIGE-23: 7-Year Results Indicate Durable Benefit of Induction Chemotherapy in Locally Advanced Rectal Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9nc1JXVkQ4cFRnaWp6bzQwbTZBNnh0UFo1ZG9JTHJrS0RxMk9Qb1A1WmJSUzJWMXpBYmlabEJPTVMtbXRBLVJkMHhiVDRSOFM2czR2YUYyVmt1RjcySmVv?oc=5","date":"2020-12-04","type":"trial","source":"Nature","summary":"Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study - Nature","headline":"Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}